Who invested in Nora Therapeutics?
Nora Therapeutics's investors include Rho Capital Partners, Novo Holdings A/S, Burrill & Company, Prospect Venture Partners and Vivo Ventures.
United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$21Mraised across 2 rounds since 2010, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $18M sold, first sale Apr 2014
No investor was named in the report.
From a historical funding recordSEC filing: $2.9M sold, first sale Mar 2009
From the SEC filings it signed: 1 on the team.
On the board, as filediAnupam K. DalalChen K. YuDavid K. SchnellDennis K. FentonDonald K. HaydenJoseph L. TurnerMartin K. Vogelbaum
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Nora Therapeutics's investors include Rho Capital Partners, Novo Holdings A/S, Burrill & Company, Prospect Venture Partners and Vivo Ventures.
Nora Therapeutics has raised $21M across 2 rounds since 2010.
Nora Therapeutics's most recent round was a Series B of $18M in Apr 2014.
Its most recent round, $18M in Apr 2014, is also its largest on record.
Nora Therapeutics's first round on record, in Apr 2014, was backed by Rho Capital Partners, Novo Holdings A/S and Burrill & Company and 2 others.
Nora Therapeutics's latest named round is a Series B, in Apr 2014.
Nora Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.